Supervisor: Carla Oliveira, PhD E-cadherin is an adhesion molecule that acts as a tumor-suppressor protein by inhibiting tumor-cell invasion and metastasis as a result of its ability to mediate cell-to-cell adhesion. Germline mutations in the E-cadherin gene (CDH1) are the underlying genetic defect responsible for hereditary diffuse gastric cancer (HDGC), with or without cleft lip 1 (OMIM 192090). An unusually high percentage (almost 80%) of CDH1 mutations generates premature termination codons (PTCs). I hypothesized that transcripts from such mutant genes are degraded by nonsense-mediated decay (NMD), an mRNA quality-control mechanism that recognizes and degrades transcripts harboring PTCs. To test this hypothesis, I examined whether PTC-containing CDH1 transcripts are downregulated by NMD. Using an allele-specifi c expression (ASE) assay to differentiate between mutated and wild-type CDH1 alleles, I observed that PTC-containing CDH1 mRNAs are strongly downregulated in normal gastric tissue from several asymptomatic CDH1 mutation carriers.
Evidence suggests that NMD modulates the phenotype of numerous diseases. In some diseases, NMD function appears to reduce the severity of the phenotype by downregulating the expression of truncated proteins with dominant-negative activity. In other diseases, NMD appears to increase disease severity by degrading transcripts encoding truncated proteins, which retain residual function. I examined the role 2 Furthermore, we obtained evidence that haploinsuffi ciency due to NMD and inactivation of the second CDH1 allele by promoter methylation is necessary for diffuse gastric cancer development. 3 Additionally, we evaluated the use of CDH1 ASE in a HDGC family under chromoendoscopic surveillance as a potential diagnostic method. CDH1 ASE was able to detect both downregulation of PTC-containing alleles in asymptomatic carries, as well as CDH1 promoter methylation of the wild-type allele in a diffuse gastric tumor. Altogether, this dissertation provides compelling evidence that NMD is detrimental for HDGC patients. The implication of this fi nding is that it will be important to develop approaches to detect and inhibit NMD as potentially useful diagnostic and therapeutic approaches in gastric tumors.
Comment by Miles Wilkinson, PhD
University of California at San Diego (UCSD) School of Medicine, Department of Reproductive Medicine, La Jolla, CA 92093, USA Hereditary syndromes that predispose to cancer are responsible for 1% to 10% of all cases of cancer and represent a serious burden for patients. Dr. Karam's dissertation focused on one such syndrome-hereditary diffuse gastric cancer (HDGC), which is caused by germline mutations of the E-cadherin gene (CDH1). In his thesis, he provided compelling evidence that HDGC is caused by transcripts downregulated by an important mRNA quality-control mechanism known as nonsense-mediated decay (NMD). Past studies have shown that NMD is a modulator of the phenotype of several diseases, including cystic fi brosis and Duchene muscular dystrophy. Dr. Karam was the fi rst to show that aberrant E-cadherin mRNA is downregulated by NMD in CDH1 mutation carriers. He defi nitively demonstrated that NMD is responsible for this downregulation, using several different approaches in a diffuse gastric cancer cell line. Additionally, he uncovered an association of predicted NMD activity with an earlier age of onset of gastric cancer in a series of E-cadherin mutation carriers. This, as well as the observation of lower cumulative risk in patients harboring a CDH1 mutation that escapes NMD, suggests that NMD has a detrimental effect on the clinical progression of HDGC. His results reinforce the idea that strong downregulation of E-cadherin (and probably other tumor suppressors in other syndromes), both by NMD and by second-hit inactivation of the wild-type allele, is a frequent and key event triggering cancer development. Consequently, NMD is a potentially useful therapeutic target in this syndrome. To analyze the effect of approaches targeting NMD, Dr. Karam investigated by microarray analysis the effect of NMD inhibition in human cancer cell lines. This analysis revealed an intricate connection between mRNA and protein quality-control mechanisms. This has large implications, as it will
